| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16c3929442960d940ef1e6aa830b57c9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate |
2019-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c6a73e213047f3d566ddb415328f08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63c4ebe2085b8ecd59226ac62453021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18519c9a5f99ab7d0d74cad85c536961
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e18dc40af58367ef0a2275642fc21080
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055086ee901f5d5468473e9ee6b34fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44507fbedbc890f617371e9dc27588a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a02e005b922da33d47912ab8813fbad |
| publicationDate |
2021-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3876942-A1 |
| titleOfInvention |
Inhibitors of human immunodeficiency virus replication |
| abstract |
Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth. |
| priorityDate |
2018-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |